Published in Knee Surg Relat Res on May 29, 2013
Venous Thromboembolism Following Hip and Knee Replacement Arthroplasty in Korea: A Nationwide Study Based on Claims Registry. J Korean Med Sci (2015) 0.80
Effect of both preoperative andpostoperative cryoceutical treatment on hemostasis and postoperative pain following total knee arthroplasty. Int J Clin Exp Med (2015) 0.75
Changing provider behavior: an overview of systematic reviews of interventions. Med Care (2001) 17.89
Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest (2008) 16.17
Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br (1996) 4.61
Femoral nerve block improves analgesia outcomes after total knee arthroplasty: a meta-analysis of randomized controlled trials. Anesthesiology (2010) 3.42
Venous thromboembolism associated with hip and knee replacement over a ten-year period: a population-based study. J Bone Joint Surg Br (2005) 2.71
Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med (1998) 2.58
Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet (2001) 2.46
Factors associated with prolonged wound drainage after primary total hip and knee arthroplasty. J Bone Joint Surg Am (2007) 2.34
Controlling pain after total hip and knee arthroplasty using a multimodal protocol with local periarticular injections: a prospective randomized study. J Arthroplasty (2007) 2.34
Preoperative or postoperative start of prophylaxis for venous thromboembolism with low-molecular-weight heparin in elective hip surgery? Arch Intern Med (2002) 2.16
Incidence and natural history of deep-vein thrombosis after total hip arthroplasty. A prospective and randomised clinical study. J Bone Joint Surg Br (2003) 2.10
Epidemiology of venous thromboembolism in Asian patients undergoing major orthopedic surgery without thromboprophylaxis. The SMART study. J Thromb Haemost (2005) 2.03
Prevention of venous thromboembolic disease following primary total knee arthroplasty. A randomized, multicenter, open-label, parallel-group comparison of enoxaparin and warfarin. J Bone Joint Surg Am (2001) 1.87
Potent anticoagulants are associated with a higher all-cause mortality rate after hip and knee arthroplasty. Clin Orthop Relat Res (2008) 1.82
Pulmonary thromboembolism in Asians/Pacific Islanders in the United States: analysis of data from the National Hospital Discharge Survey and the United States Bureau of the Census. Am J Med (2004) 1.78
Pain management and accelerated rehabilitation for total hip and total knee arthroplasty. J Arthroplasty (2007) 1.76
Multimodal pain management after total hip and knee arthroplasty at the Ranawat Orthopaedic Center. Clin Orthop Relat Res (2009) 1.68
Deep-vein thrombosis rates after major orthopedic surgery in Asia. An epidemiological study based on postoperative screening with centrally adjudicated bilateral venography. J Thromb Haemost (2005) 1.66
Effects of the medical liability system in Australia, the UK, and the USA. Lancet (2006) 1.66
New concepts in orthopaedic thromboprophylaxis. J Bone Joint Surg Br (2004) 1.64
Prophylaxis for thromboembolic disease: recommendations from the American College of Chest Physicians--are they appropriate for orthopaedic surgery? J Arthroplasty (2005) 1.61
Does anticoagulation do more harm than good?: A comparison of patients treated without prophylaxis and patients treated with low-dose warfarin after total knee arthroplasty. J Arthroplasty (2003) 1.59
A meta-analysis of thromboembolic prophylaxis following elective total hip arthroplasty. J Bone Joint Surg Am (2000) 1.57
Comparing consensus guidelines on thromboprophylaxis in orthopedic surgery. J Thromb Haemost (2009) 1.52
The efficacy of periarticular multimodal drug infiltration in total hip arthroplasty. Clin Orthop Relat Res (2009) 1.47
Does "excessive" anticoagulation predispose to periprosthetic infection? J Arthroplasty (2007) 1.45
Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients. J Thromb Haemost (2009) 1.45
Low risk of thromboembolic complications after fast-track hip and knee arthroplasty. Acta Orthop (2010) 1.44
Preventing venous thromboembolic disease in patients undergoing elective hip and knee arthroplasty. J Am Acad Orthop Surg (2011) 1.39
Mechanical prophylaxis of deep-vein thrombosis after total hip replacement a randomised clinical trial. J Bone Joint Surg Br (2004) 1.33
Thromboembolism after total hip replacement: role of epidural and general anesthesia. Anesth Analg (1983) 1.28
Early mobilisation after conventional knee replacement may reduce the risk of postoperative venous thromboembolism. J Bone Joint Surg Br (2007) 1.18
Deep venous thrombosis after total hip or total knee arthroplasty in patients in Japan. Clin Orthop Relat Res (2000) 1.18
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment. J Bone Joint Surg Am (2007) 1.13
Effects of epidural anesthesia on the incidence of deep-vein thrombosis after total knee arthroplasty. J Bone Joint Surg Am (1991) 1.10
Epidemiology of post-operative venous thromboembolism in Asian patients. Results of the SMART venography study. Haematologica (2007) 1.10
Controversies in timing of the first dose of anticoagulant prophylaxis against venous thromboembolism after major orthopedic surgery. Chest (2003) 1.08
Short-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of prospective studies investigating symptomatic outcomes. Arch Intern Med (2002) 1.04
Is routine chemical thromboprophylaxis after total hip replacement really necessary in a Japanese population? J Bone Joint Surg Br (2011) 1.03
The 2007 John Charnley Award. Factors leading to low prevalence of DVT and pulmonary embolism after THA: analysis of genetic and prothrombotic factors. Clin Orthop Relat Res (2007) 1.02
The incidence of pulmonary embolism and deep vein thrombosis after knee arthroplasty in Asians remains low: a meta-analysis. Clin Orthop Relat Res (2013) 1.02
Early mobilization after total knee replacement reduces the incidence of deep venous thrombosis. ANZ J Surg (2009) 1.01
Is anticoagulation indicated for asymptomatic postoperative calf vein thrombosis? J Vasc Surg (1992) 1.01
Failure of the American College of Chest Physicians-1A protocol for lovenox in clinical outcomes for thromboembolic prophylaxis. J Arthroplasty (2007) 1.00
The incidence of deep vein thrombosis after hip and knee arthroplasties in Japanese patients: a prospective study. J Orthop Surg (Hong Kong) (2003) 1.00
Early postoperative mortality after 67,548 total hip replacements: causes of death and thromboprophylaxis in 68 hospitals in Norway from 1987 to 1999. Acta Orthop Scand (2002) 0.99
Foot pumps without graduated compression stockings for prevention of deep-vein thrombosis in total joint replacement: efficacy, safety and patient compliance. A comparative, prospective clinical trial. Int Orthop (2007) 0.99
Systematic review and meta-analysis on the rate of postoperative venous thromboembolism in orthopaedic surgery in Asian patients without thromboprophylaxis. Br J Surg (2011) 0.98
Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg Br (2008) 0.96
Enoxaparin versus dabigatran or rivaroxaban for thromboprophylaxis after hip or knee arthroplasty: Results of separate pooled analyses of phase III multicenter randomized trials. Circ Cardiovasc Qual Outcomes (2010) 0.96
Relative risk factors for requirement of blood transfusion after total hip arthroplasty. J Arthroplasty (2007) 0.96
Duration of venous thromboembolism prophylaxis after surgery. Chest (2003) 0.93
Deep venous thrombosis after total hip or knee arthroplasty in a "low-risk" Chinese population. J Arthroplasty (2003) 0.92
Inpatient thromboprophylaxis use in U.S. hospitals: adherence to the seventh American College of Chest Physician's recommendations for at-risk medical and surgical patients. J Hosp Med (2009) 0.92
Prevention of symptomatic pulmonary embolism in patients undergoing total hip and knee arthroplasty: clinical guideline of the American Academy of Orthopaedic Surgeons. Instr Course Lect (2009) 0.89
The new AAOS clinical practice guidelines on venous thromboembolic prophylaxis: how to adapt them to your practice. J Am Acad Orthop Surg (2011) 0.89
Extended thromboprophylaxis with low molecular weight heparin reduces symptomatic venous thromboembolism following lower limb arthroplasty--a meta-analysis. Thromb Haemost (2001) 0.88
Multimodal thromboprophylaxis following primary hip arthroplasty: the role of adjuvant intermittent pneumatic calf compression. J Bone Joint Surg Br (2008) 0.88
Comparison of ACCP and AAOS guidelines for VTE prophylaxis after total hip and total knee arthroplasty. Orthopedics (2009) 0.88
Recent Korean perspective of deep vein thrombosis after total knee arthroplasty. J Arthroplasty (2011) 0.87
Pulmonary embolism prophylaxis in more than 30,000 total knee arthroplasty patients: is there a best choice? J Arthroplasty (2011) 0.86
Factors leading to decreased rates of deep vein thrombosis and pulmonary embolism after total knee arthroplasty. J Arthroplasty (2007) 0.86
The effect of anticoagulation on the restoration of range of motion after total knee arthroplasty: enoxaparin versus aspirin. J Arthroplasty (2003) 0.84
Factors leading to low incidence of deep vein thrombosis after cementless and cemented total knee arthroplasty. Clin Orthop Relat Res (1991) 0.83
The value of D-dimer in the detection of early deep-vein thrombosis after total knee arthroplasty in Asian patients: a cohort study. Thromb J (2008) 0.83
Thromboembolic prophylaxis for total knee arthroplasty in Asian patients: a randomised controlled trial. J Orthop Surg (Hong Kong) (2009) 0.82
Deep vein thrombosis after total hip arthroplasty in Korean patients and D-dimer as a screening tool. Arch Orthop Trauma Surg (2008) 0.82
The role of lumbar epidural anaesthesia as antithrombotic prophylaxis in total hip replacement. Acta Chir Scand (1985) 0.81
Implementation of the NICE guidelines for venous thromboprophylaxis; a national survey of hip surgeons. Hip Int (2009) 0.81
Clinical significance of muscular deep-vein thrombosis after total knee arthroplasty. Chang Gung Med J (2007) 0.81
Prophylaxis of venous thromboembolism in the US: improving hospital performance. J Thromb Haemost (2009) 0.80
Thromboprophylaxis dosing: the relationship between timing of first administration, efficacy, and safety. Am J Orthop (Belle Mead NJ) (2002) 0.80
Use of low molecular weight heparin for prevention of deep vein thrombosis in total knee arthroplasty--a study of its efficacy in an Asian population. Ann Acad Med Singapore (2000) 0.79
Unanswered questions, unmet needs in venous thromboprophylaxis. Orthopedics (2009) 0.78
Incidence of deep vein thrombosis following total hip arthroplasty: a Doppler ultrasonographic study. J Orthop Surg (Hong Kong) (2011) 0.78
The natural history of deep-vein thrombosis. Br J Surg (1969) 0.78
American College of Chest Physicians evidence-based guidelines for venous thromboembolic prophylaxis: the guideline wars are over. J Am Acad Orthop Surg (2012) 0.77
Multimodal prophylaxis of venous thrombosis. Am J Orthop (Belle Mead NJ) (2002) 0.76
Identification of asthma clusters in two independent Korean adult asthma cohorts. Eur Respir J (2012) 1.78
Navigation-assisted minimal invasive total knee arthroplasty in patients with extra-articular femoral deformity. J Arthroplasty (2009) 1.62
A genome-wide association study of a coronary artery disease risk variant. J Hum Genet (2013) 1.46
Soluble fms-like tyrosine kinase-1 and the progression of carotid intima-media thickness – 24-month follow-up study –. Circ J (2010) 1.41
Immunosenescent CD8+ T cells and C-X-C chemokine receptor type 3 chemokines are increased in human hypertension. Hypertension (2013) 1.32
In vivo visualization and attenuation of oxidized lipid accumulation in hypercholesterolemic zebrafish. J Clin Invest (2011) 1.27
The influence of maternal treadmill running during pregnancy on short-term memory and hippocampal cell survival in rat pups. Int J Dev Neurosci (2007) 1.15
Differential impact of metabolic syndrome on subclinical atherosclerosis according to the presence of diabetes. Cardiovasc Diabetol (2013) 1.06
Validity of the diagnosis of acute myocardial infarction in korean national medical health insurance claims data: the korean heart study (1). Korean Circ J (2012) 1.05
FADS gene polymorphisms in Koreans: association with ω6 polyunsaturated fatty acids in serum phospholipids, lipid peroxides, and coronary artery disease. Atherosclerosis (2010) 1.02
Relation between red cell distribution width with echocardiographic parameters in patients with acute heart failure. J Card Fail (2009) 1.02
Visceral adiposity and the severity of coronary artery disease in middle-aged subjects with normal waist circumference and its relation with lipocalin-2 and MCP-1. Atherosclerosis (2010) 1.01
Abnormal peripheral blood T-lymphocyte subsets in a subgroup of patients with COPD. Chest (2002) 1.01
High-resolution structure of ybfF from Escherichia coli K12: a unique substrate-binding crevice generated by domain arrangement. J Mol Biol (2008) 1.01
Brain abscess in an adult with atrial septal defect. Clin Cardiol (2010) 0.95
Combined posterolateral corner reconstruction with remnant tensioning and augmentation in chronic posterior cruciate ligament injuries: minimum 2-year follow-up. Arthroscopy (2011) 0.94
Common variants in RYR1 are associated with left ventricular hypertrophy assessed by electrocardiogram. Eur Heart J (2011) 0.92
Posterolateral corner reconstruction for posterolateral rotatory instability combined with posterior cruciate ligament injuries: comparison between fibular tunnel and tibial tunnel techniques. Knee Surg Sports Traumatol Arthrosc (2008) 0.89
Independent inverse relationship between serum lycopene concentration and arterial stiffness. Atherosclerosis (2009) 0.89
Treatment of Schatzker Type V and VI Tibial Plateau Fractures Using a Midline Longitudinal Incision and Dual Plating. Knee Surg Relat Res (2013) 0.88
Plasma adiponectin concentration and its association with metabolic syndrome in patients with heart failure. Yonsei Med J (2012) 0.88
Adiponectin and progression of arterial stiffness in hypertensive patients. Int J Cardiol (2011) 0.87
Economic costs for adult asthmatics according to severity and control status in Korean tertiary hospitals. J Asthma (2011) 0.87
Takotsubo-like severe left ventricular dysfunction after cesarean delivery in a 28-year old woman. Korean Circ J (2011) 0.87
Recent Korean perspective of deep vein thrombosis after total knee arthroplasty. J Arthroplasty (2011) 0.87
Prognostic value of change in red cell distribution width 1 month after discharge in acute decompensated heart failure patients. Circ J (2011) 0.86
The relationship between insulin-like growth factor-1 and metabolic syndrome, independent of adiponectin. Clin Chim Acta (2011) 0.86
Recombinant lentivirus-delivered short hairpin RNAs targeted to conserved coxsackievirus sequences protect against viral myocarditis and improve survival rate in an animal model. Virus Genes (2008) 0.86
Acute myocardial infarction due to vasospasm induced by prostaglandin. Can J Cardiol (2009) 0.85
Airway hyperresponsiveness is negatively associated with obesity or overweight status in patients with asthma. Int Arch Allergy Immunol (2012) 0.84
Fatal renal bleeding in a patient treated with aggressive antithrombotic therapy after recurrent coronary stent thrombosis. Korean Circ J (2010) 0.84
Attenuation of coxsackievirus B3 by VP2 mutation and its application as a vaccine against virus-induced myocarditis and pancreatitis. Vaccine (2009) 0.84
Palmitate promotes the paracrine effects of macrophages on vascular smooth muscle cells: the role of bone morphogenetic proteins. PLoS One (2012) 0.84
Comparison of arterial stiffness indices measured by the Colins and SphygmoCor systems. Hypertens Res (2012) 0.83
Effects of atorvastatin 20 mg, rosuvastatin 10 mg, and atorvastatin/ezetimibe 5 mg/5 mg on lipoproteins and glucose metabolism. J Cardiovasc Pharmacol Ther (2010) 0.83
Vascular endothelial growth factor, soluble fms-like tyrosine kinase 1, and the severity of coronary artery disease. Angiology (2010) 0.83
Current status of Oriental medicine in treating Korean allergy patients. Pharmacoepidemiol Drug Saf (2011) 0.83
Association of serum proprotein convertase subtilisin/kexin type 9 with carotid intima media thickness in hypertensive subjects. Metabolism (2013) 0.83
Serum monokine induced by gamma interferon as a novel biomarker for coronary artery calcification in humans. Coron Artery Dis (2015) 0.82
Association between Serine/Threonine Kinase 39 Gene Polymorphism, Hypertension, and Other Cardiovascular Risk Factors in Koreans. Korean Circ J (2013) 0.82
Aqueous extract of Liriope platyphylla, a traditional Chinese medicine, significantly inhibits abdominal fat accumulation and improves glucose regulation in OLETF type II diabetes model rats. Lab Anim Res (2012) 0.82
Association between CDH13 variants and cardiometabolic and vascular phenotypes in a Korean population. Yonsei Med J (2013) 0.80
Synergistic interaction between gefitinib (Iressa, ZD1839) and paclitaxel against human gastric carcinoma cells. Anticancer Drugs (2004) 0.80
Circulating IL-8 levels in heart failure patients with and without metabolic syndrome. Clin Chim Acta (2009) 0.80
Preconditioning of isoflurane on spinal cord ischemia can increase the number of inducible nitric oxide synthase-expressing motor neurons in rat. Korean J Anesthesiol (2010) 0.80
Impact of atopy on asthma and allergic rhinitis in the cohort for reality and evolution of adult asthma in Korea. Allergy Asthma Immunol Res (2012) 0.80
Serum adiponectin and type 2 diabetes: a 6-year follow-up cohort study. Diabetes Metab J (2013) 0.80
Analysis of cyclops lesions after different anterior cruciate ligament reconstructions: a comparison of the single-bundle and remnant bundle preservation techniques. Skeletal Radiol (2012) 0.79
Blocking the receptor for advanced glycation end product activation attenuates autoimmune myocarditis. Circ J (2014) 0.79
Adiponectin gene polymorphisms are associated with long-chain ω3-polyunsaturated fatty acids in serum phospholipids in nondiabetic Koreans. J Clin Endocrinol Metab (2010) 0.79
Optimal pharmacologic approach to patients with hypertriglyceridemia and low high-density lipoprotein-cholesterol: randomized comparison of fenofibrate 160 mg and niacin 1500 mg. Atherosclerosis (2010) 0.79
Augmentation index association with reactive hyperemia as assessed by peripheral arterial tonometry in hypertension. Am J Hypertens (2011) 0.79
Is Single-Radius Design Better for Quadriceps Recovery in Total Knee Arthroplasty? Knee Surg Relat Res (2015) 0.78
A case of reactive plasmacytosis mimicking multiple myeloma in a patient with primary Sjogren's syndrome. J Korean Med Sci (2005) 0.78
Clopidogrel pretreatment before primary percutaneous coronary stenting in patients with acute ST-segment elevation myocardial infarction: comparison of high loading dose (600 mg) versus low loading dose (300 mg). Coron Artery Dis (2009) 0.78
Differences between asthma in young and elderly: results from the COREA study. Respir Med (2013) 0.78
Reactive oxygen species play a critical role in collagen-induced platelet activation via SHP-2 oxidation. Antioxid Redox Signal (2014) 0.78
Is routine chemoprophylaxis necessary for prevention of venous thromboembolism following knee arthroplasty in a low incidence population? Arch Orthop Trauma Surg (2013) 0.78
Comparison of the clinical outcomes after total knee arthroplasty with the LCS rotating platform mobile bearing knee system and the PFC Sigma RP-F mobile bearing knee system. Clin Orthop Surg (2012) 0.78
Systematic analysis of attenuated Coxsackievirus expressing a foreign gene as a viral vaccine vector. Vaccine (2009) 0.77
Increased inflammation, reduced plasma phospholipid eicosapentaenoic acid and reduced antioxidant potential of treated hypertensive patients with metabolic syndrome. Yonsei Med J (2009) 0.77
Associations between Genetic Variants and Angiographic Characteristics in Patients with Coronary Artery Disease. J Atheroscler Thromb (2014) 0.77
Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient. Int J Mol Med (2010) 0.77
A genetic variant in GLP1R is associated with response to DPP-4 inhibitors in patients with type 2 diabetes. Medicine (Baltimore) (2016) 0.77
Modeling of the LDL cholesterol-lowering effect of atorvastatin in Korean dyslipidemic patients and non-patient volunteers. Int J Clin Pharmacol Ther (2012) 0.77
Central aortic pressure in aortic aneurysm and aortic dissection: a novel prognostic marker. Acta Cardiol (2010) 0.76
Systemic analysis of a novel coxsackievirus gene delivery system in a mouse model. J Microbiol Biotechnol (2009) 0.76
Aspirin-intolerant asthma in the Korean population: prevalence and characteristics based on a questionnaire survey. Respir Med (2012) 0.76
Corrective tibial osteotomy in young adults using an intramedullary nail. Knee Surg Relat Res (2014) 0.75
Does Cruciate-Retaining Total Knee Arthroplasty Show Better Quadriceps Recovery than Posterior-Stabilized Total Knee Arthroplasty? - Objective Measurement with a Dynamometer in 102 Knees. Clin Orthop Surg (2016) 0.75
Compartment syndrome following total knee arthroplasty: clinical results of late fasciotomy. Knee Surg Relat Res (2014) 0.75
Clinical and echocardiographic findings of newly diagnosed acute decompensated heart failure in elderly patients. Yonsei Med J (2011) 0.75
Three-Dimensional Reconstruction Computed Tomography Evaluation of the Tunnel Location and Angle in Anatomic Single-Bundle Anterior Cruciate Ligament Reconstruction: A Comparison of the Anteromedial Portal and Outside-in Techniques. Knee Surg Relat Res (2017) 0.75
OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality. J Hypertens (2016) 0.75
Determination of metallic impurities in a silicon wafer by local etching and electrothermal atomic absorption spectrometry. Anal Sci (2003) 0.75
Efficacy of aspirin and statins in primary prevention of cardiovascular mortality in uncomplicated hypertensive participants: a Korean national cohort study. J Hypertens (2017) 0.75
APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION. J Hypertens (2016) 0.75
OS 22-01Treatment of Hypertension with Low Cardiovascular Risk is associated with significantly lowered mortality. J Hypertens (2016) 0.75
Treatment of uncomplicated hypertension is associated with a reduction in cardiovascular mortality: a Korean national cohort study. J Hypertens (2017) 0.75
The influences of weaning age and weight on carcass traits and meat quality of pigs. Anim Sci J (2014) 0.75
Genomic structure and expression analyses of the PYGM gene in the thoroughbred horse. Zoolog Sci (2011) 0.75
The effect of intracoronary nicorandil on coronary myocardial bridging. J Cardiovasc Pharmacol Ther (2009) 0.75
Catastrophic antiphospholipid syndrome precipitated by bowel surgery. Scand J Rheumatol (2002) 0.75
Lack of association between arterial stiffness and genetic variants by genome-wide association scan. Blood Press (2015) 0.75
Drug-eluting stent thrombosis after cilostazol withdrawal in a patient previously treated with triple antiplatelet therapy. Int J Cardiol (2008) 0.75
The additive value of multiple biomarkers in prediction of premature coronary artery disease. Acta Cardiol (2015) 0.75
Left ventricular hypertrophy determines the severity of diastolic dysfunction in patients with nonvalvular atrial fibrillation and preserved left ventricular systolic function. Clin Exp Hypertens (2010) 0.75
Production of cross-reactive peptide antibodies against viral capsid proteins of human enterovirus B to apply diagnostic reagent. Microbiol Immunol (2007) 0.75
APSH YI-01 EFFECTS OF DIFFERENT CLASSES OF ANTI-HYPERTENSIVE AGENTS ON SURVIVAL IN PATIENTS WITH UNCOMPLICATED HYPERTENSION. J Hypertens (2016) 0.75